June 20, 2018 4:18 AM ET


Company Overview of Ascenta Therapeutics, Inc.

Company Overview

Ascenta Therapeutics, Inc., a biopharmaceutical company, discovers and develops medicines for the treatment of cancer. Its technology consists of agents designed to re-establish the program of apoptosis (cell death) in abnormal cancer cells. The company’s products include AT-101, a pan Bcl-2 inhibitor that directly induces apoptosis by operating as a BH3 mimetic and indirectly as a p53-independent upregulator of Noxa and Puma; AT-406, a multi-inhibitor of apoptosis protein (IAP) antagonist that promotes programmed cell death (apoptosis) in tumor cells by blocking the activity of inhibitors of apoptosis proteins or IAPs, such as XIAP, c-IAP1, c-IAP2, and ML-IAP to create conditions in which a...

101 Lindenwood Drive

Suite 405

Malvern, PA 19355

United States

Founded in 2003





Key Executives for Ascenta Therapeutics, Inc.

Co-Founder and Director
Age: 72
Vice President of Intellectual Property
Associate Director of Clinical Development
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ascenta Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.